Reference
Yamada Y, et al. First-line treatment with modified folfoxiri plus bevacizumab in patients with locally advanced colorectal cancer. Annals of Cancer Research and Therapy 28: 44-48, No. 1, 2020. Available from: URL: http://doi.org/10.4993/acrt.28.44
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1825, 41 (2020). https://doi.org/10.1007/s40278-020-84281-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-84281-x